Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

Jessica A. Shafer, Conrad R. Cruz, Ann M. Leen, Stephanie Ku, An Lu, Alexandra Rousseau, Helen E. Heslop, Cliona M. Rooney, Catherine M. Bollard, Aaron E. Foster

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Side-population (SP) analysis has been used to identify progenitor cells from normal and malignant tissues as well as revealing tumor cells with increased resistance to radiation and chemotherapy. Despite enhanced chemoresistance, tumor SP cells may still express tumor-associated antigens (TAAs), which may render them susceptible to elimination by the immune system. In this study, we show that both Hodgkin lymphoma (HL) cell lines and primary HL tumor samples contain a distinct SP phenotype. Importantly, while these cells showed increased resistance to gemcitabine, a commonly used drug for the treatment of refractory HL, HL SP cells also expressed higher levels of the TAAs MAGEA4, SSX2, survivin, and NY-ESO-1, which allowed them to be specifically recognized and killed by TAA-specific cytotoxic T lymphocytes. This study suggests that chemoresistant HL SP cells can be targeted by the immune system, providing a rationale for combined chemotherapy and immunotherapy for the treatment of HL.

Original languageEnglish (US)
Pages (from-to)870-880
Number of pages11
JournalLeukemia and Lymphoma
Volume51
Issue number5
DOIs
StatePublished - May 2010

Keywords

  • Cytotoxic T lymphocyte
  • Drug resistance
  • Hodgkin lymphoma
  • Side-population
  • Tumor-associated antigen

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this